Opportunities and challenges in tumor immunotherapy
With the development and successful application of immune checkpoint inhibitors,tumor immunotherapy has returned to another effective means in the clinical treatment of tumor.Here,we briefly reviews the current status of cumor im-munotherapy three aspects:cell therapy,immune checkpoint inbhitors,and bispecific antibodies,and disscussed the existing problems and challenges.
NETL
NSTL
万方数据
